Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure. - Wikidata - wikimedia - TriplyDB

Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.

Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.

http://www.wikidata.org/entity/Q33916951

about

Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure Regional variation of the inwardly rectifying potassium current in the canine heart and the contributions to differences in action potential repolarization The Significance of the Late Na+ Current for Arrhythmia Induction and the Therapeutic Antiarrhythmic Potential of Ranolazine.Anti-arrhythmic strategies for atrial fibrillation: The role of computational modeling in discovery, development, and optimization.Ranolazine Therapy in Cardiac Arrhythmias.Atrial-selective targeting of arrhythmogenic phase-3 early afterdepolarizations in human myocytes Ca2+ leak-What is it? Why should we care? Can it be managed?Impact of ranolazine on ventricular arrhythmias - A systematic review.Distinct Occurrence of Proarrhythmic Afterdepolarizations in Atrial Versus Ventricular Cardiomyocytes: Implications for Translational Research on Atrial Arrhythmia

P2860

Q28066307-2C6188E8-37F9-4919-898A-D7BC34372F76 Q35744240-D0ECB1FC-620E-4784-AD0A-8E2B228B4E2F Q38821307-D0F39C0B-AF5B-4A61-B6F2-C74D0E9C7054 Q38822819-8E73295D-AD04-4DF2-8125-07270CBD926D Q38881272-7D211501-4335-49BD-B8CD-E1648E774CB0 Q42540023-4ADF7417-A1CF-4BE3-A6D4-B1CEE10C705F Q47828657-D5D111C7-0718-4F36-9D36-CB7D9E4B9C97 Q52587219-A15435A8-699F-42D8-84FD-2E178BADA379 Q58728367-F9725CA4-7EEF-47A3-9571-6092C7A39984

P2860

Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.

http://www.wikidata.org/entity/Q33916951

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.

@ast

Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.

@en

type

label

Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.

@ast

Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.

@en

prefLabel

Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.

@ast

Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.

@en

P1433

Q33916951-3CC02FC7-75D7-41AD-BE0C-77566E617B38

P1476

Q33916951-DE64D51B-359C-444E-B960-7240979E3915

P2093

Q33916951-0ACB832B-B06A-45C6-B3F3-900225B86E1A

Q33916951-24485C54-600C-4F98-A545-B0DABF496940

Q33916951-443FBFA3-E176-4B0D-960F-E88A7DA374B7

Q33916951-66A329CE-654F-42DE-AC38-97C0BB947FA5

Q33916951-85C0B1E5-5D97-4D5D-A7BA-503C425E6E28

Q33916951-8B0412D9-1D00-48C3-9F96-0B4CDE8FDC59

Q33916951-F204E4E4-1FB9-4D01-A3AE-946B8CF4C0E5

P2860

Q33916951-033C25B1-5D78-435F-A001-39424C05A55E

Q33916951-05C72521-7D56-48C0-91C3-D02B1869FB46

Q33916951-0901A9FC-6B1C-45E2-9329-7BF015DDE19D

Q33916951-13A5792F-AD39-4C27-AD9F-B9E4DE68B96C

Q33916951-205FF521-5C34-4DB6-855B-613519874584

Q33916951-26A2FBDA-DD1E-4AA5-92C5-B316D4B927B4

Q33916951-33E9235A-9EA1-439B-888D-32EF20FC641B

Q33916951-373505FB-C347-458C-85F1-00E7D5718104

Q33916951-4DA3108C-EEF9-426E-BA33-5BB9229FB588

Q33916951-795FA809-51F1-4211-98DF-BB6647EB58CC

P304

Q33916951-3B12748A-2BEE-43E5-8E25-1729D03EA0AD

P31

Q33916951-184A58BF-E8F6-456C-9EC2-5B7B8D9F3773

P356

Q33916951-46A34E59-0FD8-461E-B509-1A9A2439785D

P433

Q33916951-84BC8AE4-A79A-4CE5-8F05-D46F005DBF4C

P478

Q33916951-BB3C6E58-96F3-4A32-BC7A-1E53B5AA3A25

P50

Q33916951-3C5D496B-0D6D-40B8-A2B1-F84365DD2510

Q33916951-D55084A0-C28E-4B53-8F0B-D324A55344B6

P577

Q33916951-52C210D1-1335-4363-AF0B-0D5E5437D4C9

P698

Q33916951-04F61A4B-4E0D-4774-9BE1-B1DB05F9ADFC

P932

Q33916951-208A843E-E2B7-456D-9D19-868775E1201B

P356

CIRCHEARTFAILURE.114.001129

P1433

Circulation: Heart Failure

P1476

Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure

@en

P2093

Alexander Burashnikov

http://www.w3.org/2001/XMLSchema#string

Bruce G Kornreich

http://www.w3.org/2001/XMLSchema#string

Hector Barajas-Martínez

http://www.w3.org/2001/XMLSchema#string

Jonathan M Cordeiro

http://www.w3.org/2001/XMLSchema#string

José M Di Diego

http://www.w3.org/2001/XMLSchema#string

Luiz Belardinelli

http://www.w3.org/2001/XMLSchema#string

N Sydney Moise

http://www.w3.org/2001/XMLSchema#string

P2860

Outcome of heart failure with preserved ejection fraction in a population-based study

Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity

Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria

Late sodium current contributes to diastolic cell Ca2+ accumulation in chronic heart failure.

Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).

Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current

Electrophysiologic basis for the antiarrhythmic actions of ranolazine.

P304

627-633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCHEARTFAILURE.114.001129

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Charles Antzelevitch

P577

2014-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24874201

http://www.w3.org/2001/XMLSchema#string

P932

4102661

http://www.w3.org/2001/XMLSchema#string